Determination and reversal of resistance to epirubicin intravesical chemotherapy. A confocal imaging study

British Journal of Urology

Volumn 77, Issue 6, 1996, Pages 824-829

  Duffy, P M ^a   Hayes, M C ^a   Gatrell, S K E ^a   Cooper, A ^a   Smart, C J ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bladder cancer; Confocal microscopy; Epirubicin; Multidrug resistance; Verapamil

Indexed keywords

ANTHRACYCLINE; DACTINOMYCIN; DOXORUBICIN; EPIPODOPHYLLOTOXIN; EPIRUBICIN; VALSPODAR; VERAPAMIL; VINCA ALKALOID;

ARTICLE; BLADDER CANCER; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; DRUG DISTRIBUTION; HUMAN; HUMAN CELL; INTRAVESICAL DRUG ADMINISTRATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TUMOR CELL CULTURE;

EID: 0030430249     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1996.09539.x     Document Type: Article

References (11)

1. Gottesman MM. How cancer cells evade chemotherapy: Sixteenth Richard and Hilda Rosenthal Foundation Award Lecture. Cancer Res 1993: 53: 747-54
2. Moscow JA. Schneider E, Cowan KH. Multidrug resistance. In Pinedo HM, Longo DL, Chabner BA eds. Cancer Chemotherapy and Biological Response Modifiers. Annual 14. Amsterdam: Elsevier Science, 1993: 98-117
3. Coley HM, Twentyman PR, Workman P. The efflux of anthracyclines in multidrug resistant cell lines. Biochem Pharmacol 1993; 46: 1317-26
4. Coley HM, Twentyman PR, Workman P. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A. Biochem Pharmacol 1989; 38: 4467-75
5. Roepe PD. Analysis of the steady-state and initial rate of Doxorubicin efflux from a series of multi-drug resistant cells expressing different levels of P-glycoprotein. Biochemistry 1992; 31: 12555-64
6. Coley HM, Amos PR, Twentyman PR, Workman P. Examination by confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines. Br J Cancer 1993; 67 : 1316-23
7. Gervasoni JE. Fields SZ, Krishna S et al Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res 1991; 51: 4955-63
8. Duffy PM, Hayes MC. Cooper A. Smart CJ. Determination and reversal of resistance to epirubicin intravesical chemotherapy. A flow cytometric model. Br / Urol 1996: 819-23
9. Floyd JW. Lin C, Prout JR. Multi-drug resistance of a doxorubicin-resistant bladder cancer cell line. / Urol 1990: 144: 169-71
10. Bonadonna G, ed. Advances in AnthracycHne Chemotherapy: Epirubicin. Milano: Masson Italia Editor!. 1984
11. Lane P. Vichi P. Bain DL. Tritton TR. Temperature dependence studies of adriamycin uptake on cytotoxicity. Cancer Res 1987; 47: 4038-42